Product
Artemether-Lumefantrine
3 clinical trials
2 indications
Indication
MalariaIndication
Plasmodium Vivax MalariaClinical trial
Evaluation of the Efficacy of Artemether-lumefantrine and Dihydroartemisinin-piperaquine in Children With Uncomplicated Clinical Malaria in Rural RwandaStatus: Completed, Estimated PCD: 2023-12-08
Clinical trial
Optimizing the Dose of Tafenoquine for the Radical Cure of Plasmodium Vivax Malaria in Southeast AsiaStatus: Not yet recruiting, Estimated PCD: 2027-12-31
Clinical trial
An Open-label, Randomised, Controlled, Non-inferiority Trial to Compare the Efficacy, Safety and Tolerability of a Fixed Dose Triple Artemisinin-based Combination Therapy (TACT) Artemether-lumefantrine-amodiaquine Versus First-line Artemisinin-based Combination Therapies (ACTs) for the Treatment of Uncomplicated Plasmodium Falciparum MalariaStatus: Not yet recruiting, Estimated PCD: 2024-11-30